返回 Agenda
SLS21 “Where, What, and How” of Clinical Trial Information Required by Patients: Disclosure of Investigator Site Name and Clinical Trial Results
Session Chair(s)
Miyoko Yamauchi
Clinical Leader, Specialty Clinical Development Dept.
CHUGAI PHARMACEUTICAL CO., LTD., Japan
Speaker(s)
Ryuji Hattori, MPharm
Pfizer Japan Inc., Japan
Development Operation
Kazuyuki Suzuki, MSc
Novartis Pharma K.K., Japan
Senior Lead strategy & Execution Patient Engagement group Cuntry Comms & Patient